SNES
SNES
NASDAQ · Pharmaceuticals

Senestech Inc

$1.79
-0.18 (-9.14%)
As of May 9, 2:23 AM ET ·
Financial Highlights (FY 2026)
Revenue
3.48M
Net Income
-9,986,831
Gross Margin
62.5%
Profit Margin
-287.4%
Rev Growth
+29.6%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.5% 62.5% 62.8% 62.8%
Operating Margin -292.9% -263.6% 42.6% 41.5%
Profit Margin -287.4% -273.0% 36.3% 33.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.48M 2.68M 1.47M 1.59M
Gross Profit 2.17M 1.68M 923.2K 998.4K
Operating Income -10,178,498 -7,067,856 625.4K 659.9K
Net Income -9,986,831 -6,934,764 533.2K 527.1K
Gross Margin 62.5% 62.5% 62.8% 62.8%
Operating Margin -292.9% -263.6% 42.6% 41.5%
Profit Margin -287.4% -273.0% 36.3% 33.2%
Rev Growth +29.6% +29.6% +11.3% -5.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 96.6K 96.6K 2.27M 1.95M
Total Equity 4.49M 4.49M 4.98M 4.41M
D/E Ratio 0.02 0.02 0.46 0.44
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -10,002,720 -7,331,675 838.1K 900.8K
Free Cash Flow 521.2K 519.7K